Management of Abdominal Aortic Aneurysms in 2021

Abdominal aortic aneurysms (AAA) are those of >3 cm aortic diameter.  They run the risk of rupture and ensuing death by bleeding. In consequence, they are treated to repair the aneurysm before it ruptures. 

Manejo de los aneurismas de aorta abdominal en 2021

In this regard, the most relevant predictor of rupture is aneurysm diameter. That is, the greater the aneurysm, the greater the risk. 

Randomized studies have not shown advantages in survival when <5.5 cm aneurysms were surgically treated vs. close observation. This evidence supports the use of 5.5 cm diameter as a cutoff value. Therefore, watching <5.5 cm aneurysms closely is safe and cost effective. 

Close observation, among other things, will detect aneurysms that might present accelerated sac growth (>1 cm in one year), even though we lack rigorous information to support intervention in this context. 

The key clinical points for AAA management in 2021 are:

  • Risk factors include advanced age, male sex, family history, smoking, hypercholesterolemia, and hypertension. Diabetics run the lowest risk. 
  • In men, AAA should be repaired when they are ≥5.5 cm diameter, and in women, when they are ≥5 cm.
  • Endovascular repair of AAA is associated with lower risk of perioperative complications and death vs. open surgery. 
  • The initial advantage of endovascular repair is kept for 2 or 3 years after procedure. There are no differences at long term in terms of death. 
  • Endovascular repair is associated to more reinterventions, in general simple procedures. Throughout patient life, open surgery is associated to more reinterventions due to laparotomy. 
  • For close observation, both CT and echocardiography are adequate.

Read also: TCT 2021 | STOPDAPT-2 and MASTER-DAPT: The Conversation Continues from ESC to TCT.


This is the most succinct information, and it is not much different from what have known for some time. Data are reassuring, seeing as they indicate we understand this disease, and thus we can take preventive action. 

nejmcp2108504

Original Title: Management of Abdominal Aortic Aneurysms.

Reference: Andres Schanzer et al. N Engl J Med 2021;385:1690-8. DOI: 10.1056/NEJMcp2108504.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

AHA/ACC Guideline on the Management of Acute Pulmonary Embolism 2026

The 2026 ACC/AHA guideline for the management of acute pulmonary embolism (PE) introduces a conceptual shift by replacing the traditional “risk-based” classification with an...

FFR Assessment for the Selection of Hypertensive Patients Who Benefit from Renal Stenting

Atherosclerotic renal artery stenosis (ARAS) represents one of the main causes of secondary hypertension (HTN) and is associated with a higher risk of renal...

Transcatheter Deep Vein Arterialization in Critical Limb Ischemia Without Revascularization Options

Chronic limb-threatening ischemia in patients without conventional revascularization options represents one of the most challenging scenarios within peripheral arterial disease, with 1-year major amputation...

Duration of Smoking Cessation and Risk of Amputation After Revascularization in Critical Limb Ischemia

Critical limb ischemia (CLI) is associated with high rates of amputation and mortality. Although smoking cessation improves outcomes after revascularization, the impact of the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...